TITLE:
Mechanism of Action and Efficacy of Muraglitazar in Type 2 Diabetes

CONDITION:
Diabetes Mellitus, Type 2

INTERVENTION:
Muraglitazar

SUMMARY:

      The purpose of this study is to learn more about how muraglitazar lowers blood sugar in
      people with type 2 diabetes. The safety of this treatment will also be studied.
    

DETAILED DESCRIPTION:
NONE

ELIGIBILITY:
Gender: All
Age: 18 Years to 70 Years
Criteria:

        Inclusion Criteria:

          -  Type 2 diabetes;

          -  Serum triglyceride concentration < or = 600 mg/dL;

          -  Body mass index < or = 37 kg/m2

        Exclusion Criteria:

          -  Type 1 diabetes;

          -  History of myocardial infarction (MI), coronary angioplasty, bypass graft(s),
             valvular disease, unstable angina pectoris, transient ischemic attack (TIA), or
             cerebrovascular accident (CVA) within 6 months;

          -  Congestive heart failure (NYHA Class III and IV);

          -  Uncontrolled hypertension;

          -  Women of Child Bearing Potential

          -  History of renal disease, peripheral vascular disease (PVD), pulmonary disease,
             gastrointestinal disease, active liver disease, or endocrine disease
      
